1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Synthetic Tissue Sealants Overview

3 Products under Development

• 3.1 Synthetic Tissue Sealants - Pipeline Products by Stage of Development
• 3.2 Synthetic Tissue Sealants - Pipeline Products by Territory
• 3.3 Synthetic Tissue Sealants - Pipeline Products by Regulatory Path
• 3.4 Synthetic Tissue Sealants - Pipeline Products by Estimated Approval Date
• 3.5 Synthetic Tissue Sealants - Ongoing Clinical Trials

4 Synthetic Tissue Sealants - Pipeline Products under Development by Companies

• 4.1 Synthetic Tissue Sealants Companies - Pipeline Products by Stage of Development
• 4.2 Synthetic Tissue Sealants - Pipeline Products by Stage of Development

5 Synthetic Tissue Sealants Companies and Product Overview

• 5.1 Adhesys Medical GmbH Company Overview
  • 5.1.1 Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Calmare Therapeutics Inc Company Overview
  • 5.2.1 Calmare Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Cohera Medical Inc Company Overview
  • 5.3.1 Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 GATT Technologies BV Company Overview
  • 5.4.1 GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 InVivo Therapeutics Corp Company Overview
  • 5.5.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Polyganics BV Company Overview
  • 5.6.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Samyang Biopharmaceuticals Corp Company Overview
  • 5.7.1 Samyang Biopharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview

6 Synthetic Tissue Sealants- Recent Developments

• 6.1 Jan 07, 2020: Polyganics achieves CE mark certification for LIQOSEAL
• 6.2 Sep 17, 2019: Polyganics achieves positive 3-month follow-up data of ENCASE I, the first clinical trial for LIQOSEAL

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us

Synthetic Tissue Sealants - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, “Synthetic Tissue Sealants - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Synthetic Tissue Sealants pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Synthetic Tissue Sealants are made of chemical compounds that consist of a variety of artificial components such as polyethylene glycol, synthetic peptides, and protein polymers.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Synthetic Tissue Sealants under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Synthetic Tissue Sealants and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to Buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Synthetic Tissue Sealants under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date